Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis

被引:71
作者
Farrell, PM
Li, ZH
Kosorok, MR
Laxova, A
Green, CG
Collins, J
Lai, HC
Makholm, LM
Rock, MJ
Splaingard, ML
机构
[1] Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Biostat Med Informat, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA
[4] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA
[5] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
关键词
cystic fibrosis; lung; infection; pseudomas; epidemiology; bronchopheumonia; pulmonary function;
D O I
10.1002/ppul.10336
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Children with cystic fibrosis (CF) develop bronchopulmonary disease at variable ages. Determining the epidemiology of chronic lung disease and quantifying its severity, however, have been difficult in infants and young children. As part of the Wisconsin CF Neonatal Screening Project, we were presented with an ideal opportunity to assess longitudinally the evolution of symptoms, signs, and quantitative measures of CF respiratory disease. After newborn screening test results led to early recognition, 64 patients diagnosed at a median age of 6.71 weeks were enrolled and studied systematically at a median age of 11.3 years to obtain clinical information, chest radiographs, and pulmonary function tests. Our observations revealed that a frequent cough by history is evident by 10.5 months of age in half the patients. Quantitative chest radiology (CXR scoring) demonstrated that potentially irreversible abnormalities are present in half the children by 2 years. The severity of Wisconsin and Brasfield CXR scores increased in association with respiratory infections. Longitudinal progression of Wisconsin CXR scores was related to age (P < 0.001), pancreatic insufficiency (P = 0.005), and respiratory secretion cultures positive for Staphylococus aureas (P = 0.039). In contrast, serial spirometry showed limited sensitivity, as did lung volume determinations; neither was satisfactory as repeated measures with acceptable quality control until after 7 years of age. Time to event analyses revealed that half the patients had % predicted FEF25-75 and FEV1/FVC values greater than 80% until 10.7 and 9.9 years, respectively We conclude that of the methods evaluated, quantitative chest radiology is currently the best procedure for frequent assessment of bronchopulmonary disease in CF, and that radiographic progression is evident in approximately 85% of patients by 5 years of age. Our results also suggest that bronchiectasis and other radiographic evidence of chronic infection are apparent prior to airways obstruction in young CF patients. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:230 / 240
页数:11
相关论文
共 46 条
[1]  
BLYTHE SA, 1984, CLIN BIOCHEM, V17, P277, DOI 10.1016/S0009-9120(84)90541-1
[2]  
BRASFIELD D, 1979, PEDIATRICS, V63, P24
[3]   Molecular mechanisms of developmental disorders [J].
Brodsky, M ;
Lombroso, PJ .
DEVELOPMENT AND PSYCHOPATHOLOGY, 1998, 10 (01) :1-20
[4]   High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate [J].
Brody, AS ;
Molina, PL ;
Klein, JS ;
Rothman, BS ;
Ramagopal, M ;
Swartz, DR .
PEDIATRIC RADIOLOGY, 1999, 29 (10) :731-735
[5]  
COREY M, 1976, AM REV RESPIR DIS, V114, P1085
[6]   Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis [J].
Corey, M ;
Edwards, L ;
Levison, H ;
Knowles, M .
JOURNAL OF PEDIATRICS, 1997, 131 (06) :809-814
[7]  
*CYST FIBR FDN, 2001, CYST FIBR PAT REG
[8]   Cystic fibrosis [J].
Davis, PB ;
Drumm, M ;
Konstan, MW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) :1229-1256
[9]   The decline and fall of pulmonary function in cystic fibrosis: New models, new lessons [J].
Davis, PB .
JOURNAL OF PEDIATRICS, 1997, 131 (06) :789-790
[10]   Cystic fibrosis: gene therapy or preventive gene transfer? [J].
Drittanti, L ;
Masciovecchio, MV ;
Gabbarini, J ;
Vega, M .
GENE THERAPY, 1997, 4 (10) :1001-1003